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Abstract
Background: Pharmaceutical treatment with probable anti-inflammatory substances that attack cells in various
ways including receptors, ion channels, or transporter systems may slow down the progression of inflammatory
conditions. Astrocytes and microglia are the most prominent target cells for inflammation in the central nervous
system. Their responses upon inflammatory stimuli work through the NO/cyclic GMP/protein kinase G systems that
can downregulate the ATP-induced Ca2+ signaling, as well as G protein activities which alter Na+ transporters
including Na+/K+-ATPase pump activity, Toll-like receptor 4 (TLR4), glutamate-induced Ca2+ signaling, and release of
pro-inflammatory cytokines. The rationale for this project was to investigate a combination of pharmaceutical
substances influencing the NO and the Gi/Gs activations of inflammatory reactive cells in order to make the cells
return into a more physiological state. The ATP-evoked Ca2+ signaling is important maybe due to increased ATP
release and subsequent activation of purinergic receptors. A balance between intercellular Ca2+ signaling through
gap junctions and extracellular signaling mediated by extracellular ATP may be important for physiological function.
Methods: Astrocytes in primary cultures were incubated with lipopolysaccharide in a physiological glucose
concentration for 24 h to induce inflammatory reactivity. The probable anti-inflammatory substances sildenafil and
1α,25-Dihydroxyvitamin D3 together with endomorphin-1, naloxone, and levetiracetam, were used in the presence
of high glucose concentration in the medium to restore the cells. Glutamate-, 5-HT-, and ATP-evoked intracellular
Ca2+ release, Na+/K+-ATPase expression, expression of inflammatory receptors, and release of tumor necrosis factor
alpha were measured.
Results: Sildenafil in ultralow concentration together with 1α,25-Dihydroxyvitamin D3 showed most prominent
effects on the ATP-evoked intracellular Ca2+ release. The μ-opioid agonist endomorphin-1, the μ-opioid antagonist
naloxone in ultralow concentration, and the antiepileptic agent levetiracetam downregulated the glutamate-evoked
intracellular Ca2+ release and TLR4. The combination of the pharmaceutical substances in high glucose
concentration downregulated the glutamate- and ATP-evoked Ca2+ signaling and the TLR4 expression and
upregulated the Na+/K+-ATPase pump.
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Conclusion: Pharmaceutical treatment with the combination of substances that have potential anti-inflammatory
effects, which attack different biochemical mechanisms in the cells may exert decisive effects to downregulate
neuroinflammation in the nervous system.
Keywords: Gap junction-coupled cells, Astrocytes, Inflammation, Restoration, Ca2+ signaling, Na+/K+-ATPase, TLR4,
Glucose, Pharmaceuticals,
Background
Substantial progress is made in understanding the inter-
play between chronic low-grade systemic inflammation
and diseases such as neurodegenerative, metabolic, or
autoimmune diseases and even stroke and traumatic
brain injury. Blood-brain barrier (BBB) breakdown is a
critical event in inflammation in the central nervous sys-
tem (CNS), and immune cells are involved in defense
mechanisms against pathogens [1, 2]. Microglia and as-
trocytes are responsible for the innate immune response
in the CNS, and their activation constitutes one of the
most notable characteristics of neuroinflammation. In-
flammatory processes are initiated when the glial cells
are activated [3]. The astrocytes are excitable but do not
express action potentials. They are equipped with Ca2+
signaling systems, which can be inter- and/or extracellu-
lar, and transport of small molecules between the cells
occurs through gap junctions [4–6].
It is well known that astrocytes upon inflammatory
processes are affected with an over-activation in Ca2+
signaling, which triggers astrocytes and microglia to be-
come inflammatory reactive [7]. Thereby there will be
downregulations of Na+ transporters and disruption of
the cytoskeleton. Furthermore, the release of
pro-inflammatory cytokines increases. There is increased
neuronal excitability and increased glutamate release.
Astrocyte uptake of excessive extracellular glutamate
takes place through glutamate transporters, and ionotro-
pic and metabotropic glutamate receptors are activated
[8–10]. Increased inflow of Ca2+ occurs through the
N-methyl-D-aspartate (NMDA) receptor [11]. The com-
plex Ca2+/calmodulin activates nitric oxide synthases,
which converts L-arginine to nitric oxide (NO) resulting
in accumulation of cyclic GMP and activation of protein
kinase G (PKG) [12]. Cyclic GMP is fast hydrolyzed by
phosphodiesterases (PDEs), where PDE-5 plays a central
role [3]. PDE inhibitors exert a direct anti-inflammatory
effect by raising cyclic GMP. There are indications that
the NO/cyclic GMP/PKG pathway is the central signal-
ing mechanism and can thereby be a potential tool in
diseases where inflammation, including neuroinflamma-
tory disorders, play a central role [3, 13, 14]. The potent
and selective PDE-5 inhibitor sildenafil induces cyclic
GMP accumulation, which may inhibit inflammation
[14]. It has been used in therapy in erectile dysfunction
[15] and pulmonary hypertension [16], and it affects
neuronal survival [17]. Sildenafil can also normalize
endothelial function and has been proposed for pain
therapy in humans and animals [18] due to its
anti-inflammatory properties. Furthermore, our group
has shown that sildenafil works as an anti-inflammatory
substance in lipopolysaccharide (LPS)-induced inflam-
matory reactive astrocytes and we observed that
ATP-evoked intracellular Ca2+ release was prominently
affected [19].
The opioid antagonist naloxone in ultralow concentra-
tions inhibits the Gs protein and activates the Na
+/
K+-ATPase activity. The opioid agonist endomorphin-1
activates the Gi/o protein, and the anti-epileptic agent le-
vetiracetam decreases the release of IL-1β [20, 21]. In in-
flammatory reactive astrocytes, this pharmaceutical
combination was earlier shown to restore the disorga-
nized actin filaments [21]. 1α,25-Dihydroxyvitamin D3
(vitamin D3) acts as an immune regulator to protect
against BBB disruption [22], downregulates TLR4, and
decreases TNF-α and IL-6 release [23, 24].
We cultivated astrocytes in two different glucose con-
centrations—physiological or high glucose—and com-
pared the different cultures after stimulation with
sildenafil. The hypothesis is that cells grown in physio-
logical glucose concentration increase the inflammatory
reactivity better than cells grown in high glucose con-
centration. High glucose might have anti-inflammatory
properties [25].
The first purpose of this study was to evaluate the
anti-inflammatory effects of sildenafil (Viagra®) in glial
cells. The hypothesis is that the NO/cyclic GMP/protein
kinase G systems can downregulate intracellular Ca2+ re-
lease evoked by ATP and maybe also have effects on in-
flammatory receptors. We tested the effects on cells
cultivated in low and high glucose concentrations,
respectively.
The second purpose was to evaluate the effects of the
combination of the μ-opioid receptor antagonist, nalox-
one, at ultralow concentrations, the μ-opioid receptor
agonist, endomorphin-1, and levetiracetam, earlier
shown by us to affect glutamate-evoked intracellular Ca2
+ release [21, 26]. This was done in combination with
sildenafil in ultralow concentration and vitamin D3,
which affect ATP-evoked intracellular Ca2+ release. Our
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hypothesis is that inflammatory processes influence the
glutamate- and ATP-induced Ca2+ release as well as in-
flammatory receptors and the Na+/K+-ATPase pump ac-
tivity. Ca2+ responses to ATP stimulation is changed due
to inflammation and mediated by extracellular diffusion
of ATP leading to activation of purinergic receptors.
Thus, we want to affect these biochemical systems with
substances, which have probable anti-inflammatory ef-
fects in the nervous system.
Methods
Cell model system
Primary cortical astrocytes from Sprague Dawley new-
born rats were purchased from 3H Biomedical Science
(Uppsala, Sweden) and prepared according to the manu-
facturer’s instructions with some modifications [8, 21].
The cultures were delivered in 5.5 mM glucose and cul-
tivated in 5.5 mM glucose (normal concentration) the
whole period. In some experiments, the cells were culti-
vated in 25 mM glucose (high concentration) the whole
period.
LPS treatment and pharmaceutical restoration
To evaluate an optimal LPS concentration, a concentra-
tion curve including 0, 1, 10, 100, 500, and 1000 ng/ml
evaluated by tumor necrosis factor alpha (TNF-α) re-
lease was used. The cells were incubated for 24 h.
For anti-inflammatory restoration, the cell cultures
were incubated with LPS for 24 h. Restoration proceeds
so that the cells are incubated with the pharmaceutical
substances together with LPS for further 24 h. Sub-
stances are naloxone (10−12 M) (Sigma Aldrich, St. Louis,
MO, USA), endomorphin-1 (10−6 M) (Sigma Aldrich),
levetiracetam (10−4 M) (Sigma Aldrich), sildenafil citrate
salt (1 μM) (Sigma Aldrich), and 1α,25-Dihydroxyvita-
min D3 (100 nM) (Sigma Aldrich).
Cytokine release
TNF-α (BD Biosciences, San Diego, USA) was used ac-
cording to the manufacturer’s instructions to measure
the amount of cytokine released with ELISA. Between
every incubation step, several washes were performed.
The amount of TNF-α release was normalized to the
protein content.
Immunocytochemistry
The cells were fixed with 4% paraformaldehyde (Bie &
Berntsen, Herlev, Denmark) for 10 min and washed
twice with phosphate buffer saline (PBS) (Invitrogen,
Carlsbad, USA) containing 1% BSA (PBS-BSA). The cells
were permeabilized with PBS-BSA containing 0.05%
saponine (PBS-BSA-Sap) for 20 min. Thereafter, the cells
were incubated for 1 h with a cocktail of rabbit poly-
clonal antibody against glial fibrillary acidic protein
(GFAP) (Dako, Glostrup, Denmark) and a mouse mono-
clonal antibody against OX42 (Serotec Oxford, UK).
Both antibodies were diluted 1:100 in PBS-BSA-Sap. The
cells were washed with PBS-BSA-Sap for 3 × 5 min and
then incubated with a mixture of FITC-conjugated
F(ab´)2 fragment donkey anti-mouse IgG and a Dylight
594-conjugated F(ab´)2 fragment donkey anti-rabbit IgG
secondary antibodies (Jackson ImmunoResearch Europe
Ltd., Suffolk, UK), both diluted 1:150. The cells were
washed with PBS-BSA-Sap for 3 × 5 min and finally
rinsed with PBS. The cover slips were mounted on
microscope slides with a fluorescent mounting medium
(Dako) and viewed in a Nikon Eclipse 80i microscope.
Pictures were taken with a Hamamatsu C5810 colour in-
tensified 3CCD camera.
Cell counting
Regions for cell counting were sampled randomly. In
each culture slide, five areas were chosen randomly and
three cultures from each type of experiments were done
to ensure any differences in the cultures.
Calcium imaging
With a high-throughput screening system for intracellu-
lar Ca2+ signaling, Flexstation 3 Microplate Reader (Mo-
lecular Devices, San José, USA), the cells were incubated
with the Ca2+-sensitive probe FLIPR Calcium 6 (Molecu-
lar Devices) and stimulated immediately before the ex-
periment started with different neurotransmitters—
5-HT (10− 5 M), glutamate (10− 3 M), or ATP (10− 4 M)
all from Sigma Aldrich (Saint Louis, USA). The intracel-
lular Ca2+ release was determined as the total areas
under the curve (AUC), which reflects the amount of
Ca2+ released [27]. The amplitude (peak) was expressed
as the maximum increase.
SDS-PAGE and Western blotting
The cells were rinsed twice in phosphate buffered saline
(PBS) and immediately lysed for 20 min on ice in cold
radio-immunoprecipitation assay (RIPA) lysis buffer con-
taining 150 mM NaCl, 1% IGEPAL® CA-630, 0.5% so-
dium deoxycholate, 0.1% SDS, 50 mM Tris, (pH 8.0),
supplemented with a protease inhibitor cocktail contain-
ing 104 mM AEBSF, 80 μM aprotinin, 4 mM bestatin,
1.4 mM E-64, 2 mM leupeptin, and 1.5 mM pepstatin A.
The procedure was performed according to Persson et
al. [28]. Separate aliquots were collected to determine
the protein concentration. All of the samples were ana-
lyzed for the total protein content, and 20 μg of the total
protein from each sample was loaded into each lane of
the gel. β-Actin was used as a control for equal loading.
SDS-PAGE was conducted using the Novex pre-cast
gel system (Invitrogen) according to the manufacturer’s
recommendations using 4–12% Bis-Tris gels (Invitrogen)
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at 200 V for 50 min. The separated proteins were trans-
ferred at 30 V for 60 min to a nitrocellulose membrane
(Invitrogen) using NuPAGE transfer buffer (Invitrogen)
supplemented with methanol and NuPAGE antioxidant.
The membranes were rinsed twice with distilled water,
and the proteins were visualized with Ponceau S solution
(Sigma Aldrich). The proteins were blocked with 0.5%
fat-free skim milk (Semper AB, Götene, Sweden) in
Tris-buffered saline (TBST; 50 mM Tris-HCl, 150 mM
NaCl, and 0.05% Tween) for 60 min at room
temperature. The membranes were probed with
anti-TLR4 (rabbit polyclonal, 1:500) (Santa Cruz Biotech
Inc., Dallas, TX, USA), anti-NK-1 (rabbit polyclonal,
1:1000) (LifeSpan BioSciences Inc., Seattle, USA),
anti-PAR-2 (rabbit polyclonal, Santa Cruz Biotech Inc),
or a mouse monoclonal primary antibody against Na+/
K+-ATPase (α-subunit) (Sigma Aldrich) diluted 1:250,
washed four time for 2 min with TBST, followed with
the secondary horseradish peroxidase (HRP)-conjugated
antibodies, donkey anti-mouse, or anti-rabbit F(ab’)2
fragment (Jackson ImmunoResearch) diluted 1:10000,
also washed several times in TBST. All of the primary
and secondary antibodies were diluted in 0.5% fat-free
skim milk in TBST. The antibody-bound protein was de-
tected with an enhanced chemiluminescence kit (Perki-
nElmer Inc., Waltham, MA, USA) and visualized using
Fuji Film LAS-3000 (Tokyo, Japan).
Protein determination
The protein determination assay was performed in ac-
cordance with the manufacturer’s instructions using a
detergent-compatible (DC) Protein Assay (Bio-Rad,
Hercules, CA, USA) based on the method used by
Lowry and co-workers [29] with minor modifications.
The standard (0–4 mg/ml BSA) and samples were mixed
with the reagents, incubated for 15 min at room
temperature, read at 750 nm with a Versa-max micro-
plate reader, and analyzed using SoftMax Pro 4.8 from
Molecular Devices (Sunnyvale, CA, USA).
Statistical analysis
Differences across the different treatments were identi-
fied using a one-way ANOVA followed by Dunnett’s
multiple comparisons test. The error bars represent the
standard error of the mean (SEM).
Results
Astroglial cultures
The astroglial cultures contain some few percents of
microglial cells, less than 5% when bought from the sup-
plier. It has turned out through our experiments the ne-
cessity to have a critical number of microglia in the
astroglial cultures to obtain reactive inflammatory astro-
cytes after incubation with LPS. The amount of microglia
increased to 5–10% when the cultures were incubated
with LPS (10 ng/ml) for 24 h. When the cultures were in-
cubated first with LPS for 24 h followed by incubation
with LPS and sildenafil (1 μM) [19] for another 24 h, the
number of microglial cells decreased, less than 5% (Fig. 1).
LPS treatment
The LPS concentration was evaluated with a concentra-
tion curve. 10 ng/ml LPS turned out to be the optimal
concentration verified by TNF-α release (Fig. 2). In all
further experiments, 10 ng/ml LPS were used.
Evaluation of physiological and high glucose
concentration
Astrocytes in culture, cultivated in 5.5 mM glucose
physiological concentration, achieve inflammatory re-
activity when incubated with LPS for 24 h. Astrocytes
cultivated in high glucose concentration, 25 mM, were
very difficult or impossible to achieve inflammatory re-
activity. This is visualized with the intracellular evoked
Ca2+ release (Fig. 3) and expression of several inflamma-
tory receptors such as the TLR4, the substance P recep-
tor (NK-1), and the tryptase receptor (PAR-2) (Fig. 4).
Referring to intracellular evoked Ca2+ release, no differ-
ences were obtained in the control cultures cultivated in
physiological or high glucose concentration during the
whole cultivation period (Fig. 3). When incubated with
LPS for 24 h, only those cultures cultivated in 5.5 mM glu-
cose evoked increased Ca2+ release after the cells were
stimulated with 5-HT, glutamate, or ATP (Fig. 3).
Concerning expression of the inflammatory receptors
TLR4, NK-1, and PAR-2 (Fig. 4), the cells cultivated in
physiological glucose concentration increased their expres-
sion of the inflammatory receptors when incubated with
LPS for 24 h. Cultivation in high glucose did not change
the expression of either inflammatory receptor (Fig. 4).
Restoration of inflammatory reactive astrocytes cultivated
in high glucose concentration
An extremely low concentration of sildenafil, 1 μM, was
found to be optimal for ATP-evoked intracellular Ca2+
release [19]. For anti-inflammatory restoration back to a
normal physiological level, the cells were first incubated
with LPS for 24 h followed by LPS + sildenafil for further
24 h. The cells were cultivated in physiological or high
glucose concentrations from start.
Cells cultivated in 5.5 mM glucose and stimulated with
LPS reached inflammatory reactivity. However, cells cul-
tivated in 25 mM glucose attenuated the 5-HT-, glutam-
ate- and ATP-evoked Ca2+ release compared to LPS
incubated inflammatory cells cultivated in 5.5 mM glu-
cose (Fig. 3).
The expression of TLR4, NK-1, or PAR-2 receptors
decreased when the cells were cultivated in 25 mM
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glucose, stimulated with LPS and sildenafil compared
to cells cultivated in 5.5 mM glucose and stimulated
with LPS (Fig. 4). The results show that sildenafil
decreased inflammatory markers.
As sildenafil is a potent and selective PDE-5 inhibitor,
we show that our astrocytes also express PDE-5, which
were not changed in expression after the cells were incu-
bated with LPS (Fig. 5).
Restoration of inflammatory reactive astrocytes cultivated
in physiological glucose concentration
Restoration of inflammation-reactive astrocytes with a
combination of three substances—an opioid agonist, an
opioid antagonist, and an anti-epileptic substance—has
earlier been tested. These results showed that only the
glutamate-induced Ca2+ signaling was influenced [21,
26]. We hypothesize that even the ATP-evoked Ca2+ sig-
naling is important maybe due to increased ATP release
[7] and subsequent activation of purinergic receptors. A
balance between intercellular Ca2+ signaling through gap
junctions and extracellular signaling mediated by extra-
cellular ATP is preferred.
Astrocytes in the following experiments were all culti-
vated in 5.5 mM glucose from the start. To become in-
flammatory reactive, the cells were incubated with LPS
for 24 h. For restoration, the cells continued with LPS +
Fig. 1 Culture stained for OX42, a marker for microglial cells (green), and GFAP, a marker for astrocytes (red). Some microglia, less than 5%, were found
in the control cultures ©, 5.5 mM glucose. The amount of microglia increased to 5–10% after treatment with LPS for 24 h in 5.5 mM glucose. The
amount of microglia decreased after treatment with LPS for 24 h followed by incubation with LPS and sildenafil (Sild) for another 24 h in 5.5 mM
glucose to less than 5%. Cultures cultivated in 25 mM glucose were less affected, 1–2%. Scale bar = 50 μm. Representative images are presented
Fig. 2 LPS concentration curve verified by TNF-α release. n = 6
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Fig. 3 (See legend on next page.)
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addition of high glucose together with pharmaceuticals
in combination for additional 24 h: (1) the μ-opioid an-
tagonist naloxone in ultralow concentration, the
μ-opioid agonist endomorphin-1, and the anti-epileptic
agent levetiracetam, (2) ultralow concentration of silden-
afil and vitamin D3, (3) combination (1) and (2).
The glutamate-evoked intracellular Ca2+ release was
restored back to a normal Ca2+ signaling with the com-
bination of the μ-opioid antagonist naloxone in ultralow
concentration, the μ-opioid agonist endomorphin-1, and
the anti-epileptic agent levetiracetam (Fig. 6). The ATP
evoked intracellular Ca2+ release was restored back to a
normal Ca2+ signaling with the combination of sildenafil
and vitamin D3 (Fig. 6).
The combination of high glucose concentration to-
gether with ultralow concentration naloxone,
endomorphin-1, levetiracetam, ultralow concentration
sildenafil, and vitamin D3 restored the inflammatory in-
duced astrocytes back to a physiological Ca2+ signaling
regarding both the glutamate- and ATP-evoked Ca2+ sig-
naling. The 5-HT-evoked Ca2+ signaling was not affected
(Fig. 6). Additional control data for LPS + glucose, LPS +
(See figure on previous page.)
Fig. 3 Astrocytes were stimulated, in a fluorescence-based assay for detecting changes in intracellular Ca2+ over time, with the following: 5-HT
(10−5 M), glutamate (10−3 M), or ATP (10−4 M). The cells were cultivated in 5.5 mM or 25mM glucose the whole cultivation period. Ca2+ responses
when incubated with LPS (10 ng/ml) for 24 h, or when incubated with LPS for 24 h followed by LPS and sildenafil (Sild) (1 μM); unstimulated cells
were used as controls ©. The area under the Ca2+ peak (AUC) was calculated for each Ca2+ transient, and the amplitude (peak) was expressed as
the maximum increase. The cells were obtained from three experiments with quadruple wells in each. The level of significance was calculated
against LPS (5.5) and analyzed using one-way ANOVA followed by Dunnett’s multiple comparisons test. *P < 0.05, **P < 0.01, ***P < 0.001. Separate
small histograms show cells cultivated in 5.5 mM glucose and 25 mM glucose, respectively. The level of significance was calculated against LPS
(5.5) or against LPS (25). *P < 0.05
Fig. 4 Expression levels of the receptors TLR4, NK-1, and PAR-2 were studied using Western blot analysis. Astrocytes were cultivated in 5.5 mM or
25mM glucose the whole cultivation period. The astrocytes were incubated with LPS (10 ng/ml) for 24 h or incubated with LPS for 24 h followed
by LPS and sildenafil (Sild) (1 μM), or combination of all substances for another 24 h; unstimulated cells were used as controls ©. Statistical
analysis: the level of significance was calculated against LPS (5.5) and analyzed using one-way ANOVA followed by Dunnett’s multiple
comparisons test. *P < 0.05, **P < 0.01. n = 6. Separate small histograms show cells cultivated in 5.5 mM glucose and 25 mM glucose, respectively.
The level of significance was calculated against LPS (5.5) or against LPS (25). *P < 0.05. Representative images of Western blot membranes
are presented
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glucose + sildenafil, LPS + glucose + vitamin D3, and LPS
+ glucose + sildenafil + vitamin D3 for clarification to
Fig. 6 are shown (Fig. 6).
Expression of the receptors TLR4 and NK-1 showed
that TLR4 was attenuated by combination 1, 2, and 1 +
2. No effect was seen with the NK-1 receptor (Fig. 7).
Expression of Na+/K+-ATPase increased after stimula-
tion with the combination 1 + 2 (Fig. 7). Additional con-
trol data for LPS + glucose, LPS + glucose + sildenafil, LPS
+ glucose + vitamin D3, and LPS + glucose + sildenafil +
vitamin D3 for clarification to Fig. 7 are shown (Fig. 7).
Discussion
Gap junction coupled cellular networks can be target
cells leading to spread of inflammation and changes in
biochemical cellular parameters. Astrocytes in the CNS are
the most well-studied network coupled cells in the body
[30], which play a pivotal role in chronic neuroinflamma-
tion [31, 32]. Aims are to restore inflammatory influenced
coupled cell networks back to a physiological level.
Different pharmaceutical combinations were shown to
exert powerful anti-inflammatory effects on the astrocytes
in culture. Sildenafil in ultralow concentration showed
prominent effects on the ATP-evoked intracellular Ca2+ re-
lease in accordance with our previous results [19]. The
combination of sildenafil and vitamin D3 showed even bet-
ter effects. The main effect of the combination of the
μ-opioid receptor antagonist naloxone in ultralow concen-
trations, the μ-opioid receptor agonist, endomorphin-1,
and levetiracetam was a decrease in the glutamate-evoked
Fig. 5 The expression levels of PDE-5 were studied using Western blot analysis. Astrocytes were cultivated in 5.5 mM glucose the whole
cultivation period. The astrocytes were incubated with LPS (10 ng/ml) for 24 h or incubated with LPS for 24 h followed by LPS and sildenafil (Sild)
(1 μM) for another 24 h. n = 3. Representative image of Western blot membrane is presented
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intracellular Ca2+ release [21] and a reinforcement of the
Na+ transporters including the Na+/K+ ATPase and down-
regulation of TLR4. Clinical tests in patients with naloxone
in ultralow concentrations in combination with morphine
have shown promising results [33] as anti-inflammatory
pharmaceuticals.
Astrocytes in culture were cultivated during the whole
period in either physiological glucose concentration,
5.5 mM, or in high glucose concentration, 25 mM. Com-
mercial cell batches are delivered in high glucose, prob-
ably to achieve viable and more stable cells. However,
we experienced difficulties to achieve inflammatory re-
activity with LPS in cells cultivated in high glucose.
Therefore, we ordered cells cultivated in 5.5 mM glu-
cose. Inflammatory reactivity was easier to induce in
physiological glucose, which we verified concerning
Fig. 6 Astrocytes were stimulated, in a fluorescence-based assay for detecting changes in intracellular Ca2+ over time, with the following: 5-HT(10−5
M), glutamate (10−3 M), or ATP (10−4 M). AUC and peak values of Ca2+ transients are shown. The cells were cultivated in 5.5mM glucose the whole
cultivation period. Ca2+ responses were measured after the cells were incubated with LPS (10 ng/ml) for 24 h, when incubated with LPS for 24 h
followed by LPS, 25mM glucose, a combination of naloxone (Nal) (10−12 M), endomorphin-1 (EM-1) (10−6 M), and levetiracetam (Lev) (10−4 M), or a
combination of sildenafil (Sild) (1 μM) and vitamin D3 (D3) (100 nM) or combination of all substances for another 24 h. Unstimulated cells were used as
controls. The area under the Ca2+ peak (AUC) was calculated for each Ca2+ transient, and the amplitude (peak) was expressed as the maximum
increase. The cells were obtained from four experiments with quadruple wells in each. The level of significance was calculated against LPS (5.5) and
analyzed using one-way ANOVA followed by Dunnett’s multiple comparisons test. *P < 0.05, **P < 0.01, ***P < 0.001. Additional data, small histograms,
for LPS + glucose, LPS + glucose + sildenafil, LPS + glucose + vitamin D3, and LPS + glucose + sildenafil + vitamin D3. * P < 0.05
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5-HT-, glutamate- and ATP-evoked Ca2+ signaling, and
expression with the inflammatory receptors TLR4, NK-1,
and PAR-2. The results suggest that cultivation in high
glucose at least partly protected the cells from inflam-
matory reactivity.
The number of microglial cells in the cultures seems
important for the possibility to induce inflammatory re-
active astrocytes, and a minimum number of microglia
has been shown to be approximately 5%. Due to this, it
can be discussed whether or not the biochemical re-
sponses obtained in this paper is dependent on micro-
glial or astroglial activation, or both. It is plausible that
microglial activation influences upon the astroglial bio-
chemical machinery, but the amount of microglia in the
cultures were too small to be responsible for the overall
responses and results obtained. In addition, it should be
noted that the Ca2+ experiments were performed on sin-
gle astroglial cells. This matter has been evaluated and
discussed earlier by us [8].
One question is whether or not there is a decreased
glucose uptake in inflammatory reactive astrocytes de-
pending on dysfunctioning glucose protein transporters,
which can in turn lead to the development of cell starva-
tion. If the glucose uptake does not work in a proper
Fig. 7 Expression levels of TLR4, NK-1, and Na+/K+-ATPase were studied using Western blot analysis. Astrocytes were cultivated in 5.5 mM glucose
the whole cultivation period. The cells were incubated with LPS (10 ng/ml) for 24 h, when incubated with LPS for 24 h followed by LPS, 25 mM
glucose, a combination of naloxone (Nal) (10− 12 M), endomorphin-1 (EM-1) (10− 6 M), and levetiracetam (Lev) (10− 4 M), or a combination of
sildenafil (Sild) (1 μM) and vitamin D3 (D3) (100 nM), or combination of all substances for another 24 h. Unstimulated cells were used as controls.
The level of significance was calculated against LPS (5.5) and analyzed using one-way ANOVA followed by Dunnett’s multiple comparisons test.
*P < 0.05, **P < 0.01, ***P < 0.001. n = 6. Representative images of Western blot membranes are presented. Additional data, small histograms
below, show LPS + glucose, LPS + glucose + sildenafil, LPS + glucose + vitamin D3, and LPS + glucose + sildenafil + vitamin D3
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way in astrocytes, glucose degradation, glycolysis, an im-
portant function that supports signaling mechanisms in
the brain, is reduced [34]. Glutamate induces glucose
transporter (GLUT1) activity and thereby uptake rates in
astrocytes [35]. For this astrocytic metabolism, which
consumes ATP, the Na+/K+-ATPase activity is increased
and necessary for intercellular Ca2+ waves [36] as well as
for intercellular Na+ waves [37]. Glucose transport in
systemic inflammation and in autoimmune diseases is
changed. It is observed that organs other than the brain
enhance its glucose uptake, but brain cells react in a dif-
ferent way. It is discussed whether reduced glucose up-
take is a result of lower blood flow or insufficient
glucose uptake due to subnormal glucose transport [38].
The knowledge on glucose transport and the role of glu-
cose transporters is incomplete and needs further
investigations.
If we take the clinical problem into consideration, pa-
tients suffering in neuroinflammation may have glucose
transporters that do not work in a proper way. A chal-
lenge to the problem is to test combinations of pharma-
ceutical substances that can restore inflammatory
cellular parameters. The glial cultures are cultivated in
physiological glucose concentration to achieve inflam-
matory reactivity. In the restoration process, high glu-
cose is added to activate the glucose transporter systems.
The LPS-induced astrocytes were stimulated with differ-
ent pharmaceutical combinations together with high glu-
cose [25].
Sildenafil in ultralow concentrations decreased the
ATP-evoked Ca2+ signaling [19]. It turned out that the
glial cells grown in normal glucose were restored with
pharmaceuticals that have anti-inflammatory properties
in combination with high glucose.
ATP is involved in many cellular signaling systems and
increased ATP release from excitable astrocytes leads to
increased extracellular Ca2+ signaling [39, 40]. An en-
hanced extracellular ATP concentration as a result of
astrocyte activation is seen in inflammatory diseases [41].
We also received increased ATP-evoked Ca2+ signaling in
inflammatory induced astrocytes. The ATP-evoked Ca2+
signaling decreased to control level with an ultralow con-
centration of sildenafil in combination with vitamin D3.
The potent and selective PDE-5 inhibitor sildenafil [14]
has shown to have anti-inflammatory and neuroprotective
effects maybe through modulation of AMP-activated pro-
tein kinase (AMPK) and NF B signaling [42]. AMPK
also promotes glucose uptake [43]. Furthermore, sildenafil
reduces the expression of the pro-inflammatory cytokines
IL-1β and TNF-α [44]. It is suggested that the cGMP
pathway may regulate responses after inflammatory induc-
tion including the cellular cytoskeleton [45].
Vitamin D3, a neuroprotective hormone which acti-
vates its receptor vitamin D receptor (VDR), protects
against BBB disruption in endothelial cells in microves-
sels [22]. VDR is expressed in all tissues including astro-
cytes [46]. Vitamin D3 acts as an immune regulator and
a stimulator of neurotrophic factors and neurotransmit-
ter expression [23]. Furthermore, vitamin D3 downregu-
lates TLR4 and decreases TNF-α and IL-6 release [23,
24]. As vitamin D3 attenuates inflammatory responses,
we included it in our pharmaceuticals for the restoration
of inflammatory reactive astrocytes.
It is well known that μ-opioid receptor agonists stimu-
late the Gi/o protein of the μ-opioid receptor. In the
chronic administration of morphine or increased en-
dogenous production of endomorphin, a switch in G
protein coupling from Gi/o to Gs proteins occurs. It is
found important to stimulate Gi/o proteins and decrease
Gs protein activities [21]. Naloxone in ultralow concen-
tration inhibits the Gs protein. Thereby, a switch of the
μ-opioid receptor coupling back to the Gi/o proteins oc-
curs. This is discussed in [21]. The anti-epileptic drug le-
vetiracetam decreases interleukin-1β release and has
anti-inflammatory properties [20, 21]. The combination,
the μ-opioid antagonist naloxone in ultralow concentra-
tion, the μ-opioid agonist endomorphin-1, and the
anti-epileptic agent levetiracetam, had only effects on
the glutamate-evoked intracellular Ca2+ release. The
5-HT- and ATP-evoked intracellular Ca2+ release does
not seem to be affected.
The results show that high glucose together with the
ultralow concentration of sildenafil and vitamin D3 at-
tenuated the intracellular Ca2+ release evoked by ATP.
Also, the inflammatory receptors, TLR4, NK-1, and
PAR-2, were decreased in protein expressions. The com-
bination in high glucose together with the μ-opioid an-
tagonist naloxone in ultralow concentration, the
μ-opioid agonist endomorphin-1, the anti-epileptic agent
levetiracetam, ultralow concentration sildenafil, and vita-
min D3 restored both the glutamate- and ATP-evoked
intracellular Ca2+ release back to a physiological homeo-
stasis. Furthermore, the Na+ transporters including the
Na+/K+-ATPase pump were increased and the release of
pro-inflammatory cytokines, glutamate release, and
TLR4 expression were reduced.
Taken together, our results show that by combining dif-
ferent pharmaceuticals with possible anti-inflammatory
actions, important biochemical processes may be influ-
enced upon.
Conclusions
We show that cultivating astrocytes in low glucose con-
centration induce inflammatory reactivity after incubation
with LPS. Sildenafil in ultralow concentration in combin-
ation with vitamin D3 had prominent effects on the
ATP-evoked intracellular Ca2+ release. The μ-opioid agon-
ist endomorphin-1, the μ-opioid antagonist naloxone in
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ultralow concentration, and the antiepileptic agent leveti-
racetam downregulated the glutamate-evoked intracellular
Ca2+ release and TLR4. The combination of the pharma-
ceuticals in high glucose downregulated the ATP- and
glutamate-evoked Ca2+ signaling and the expression of
TLR4. The expression of the Na+/K+-ATPase pump was
upregulated.
Our unique results suggest that a combination of
pharmaceuticals is necessary to restore vital cellular
functions in astrocytes and thus inflammatory processes
could be inhibited or restored. Our purpose is now to
continue with pre-clinical and clinical trials in vivo.
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